Higher Margins: Dr. Thomas Ichim, Board Member of the Company, and co-inventor of the manufacturing patent. "As we prepare to launch the Phase III clinical trial in COVID-19 we need to ensure that manufacturing procedures utilized are practical and economical. The data generated by the team, as well as the various advancements that we have filed intellectual property on significantly reduce the cost of production."